PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,149,222 | -18.6% | 265,620 | +6.3% | 0.80% | -13.1% |
| Q2 2023 | $10,014,294 | -4.7% | 249,920 | -3.0% | 0.92% | -6.5% |
| Q1 2023 | $10,509,391 | -1.6% | 257,520 | -6.9% | 0.98% | -1.2% |
| Q4 2022 | $10,679,140 | -24.0% | 276,590 | +4.6% | 0.99% | -28.7% |
| Q3 2022 | $14,059,000 | -31.0% | 264,315 | -24.4% | 1.39% | -12.7% |
| Q2 2022 | $20,388,000 | -15.8% | 349,700 | +10.2% | 1.60% | -1.9% |
| Q1 2022 | $24,226,000 | +22.8% | 317,425 | -3.2% | 1.63% | +48.0% |
| Q4 2021 | $19,727,000 | -43.4% | 327,850 | -47.3% | 1.10% | -46.9% |
| Q3 2021 | $34,838,000 | -11.2% | 622,100 | -3.8% | 2.07% | -9.8% |
| Q2 2021 | $39,231,000 | -7.2% | 646,530 | +7.2% | 2.30% | -9.5% |
| Q1 2021 | $42,254,000 | +18.2% | 602,860 | +1.0% | 2.54% | +7.0% |
| Q4 2020 | $35,733,000 | +37.7% | 597,145 | +38.3% | 2.37% | +11.0% |
| Q3 2020 | $25,954,000 | – | 431,700 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |